O. Moreau

Current developments in stepwise edman degradation of peptides and proteins

G. Briand, Kia-Ki Han, D. Belaiche, 1985 .

Specific secretion of gel-forming mucins and TFF peptides in HT-29 cells of mucin-secreting phenotype.

V. Gouyer, G. Huet, T. Lesuffleur, 2001, Biochimica et biophysica acta.

Evidence for the resistance of thyrotropin-releasing hormone (TRH) and pseudo-hormone, pyroglutamyl histidyl-amphetamine, to degradation by enzymes of the digestive tract in vitro.

B. Debuire, K. Han, O. Moreau, 1979, Biochimie.

Evidence for the enzymic degradation of thyrotropin-releasing-hormone (TRH) and pseudo-hormone (pyroglutamyl-histidyl-amphetamine) by calf liver pyroglutamine-amino-peptidase.

K. Han, O. Moreau, M. Masson, 1979, The International journal of biochemistry.

Differential mucin expression in colon carcinoma HT‐29 clones with variable resistance to 5‐fluorouracil and methotrexate

V. Gouyer, G. Huet, A. Barbat, 2004, Biology of the cell.

Characterization of mucins and proteoglycans synthesized by a mucin-secreting HT-29 cell subpopulation.

F. Real, G. Huet, B. Hémon, 1995, Journal of cell science.

Permanent exposure of mucin-secreting HT-29 cells to benzyl-N-acetyl-alpha-D-galactosaminide induces abnormal O-glycosylation of mucins and inhibits constitutive and stimulated MUC5AC secretion.

F. Real, G. Huet, T. Lesuffleur, 1998, The Biochemical journal.

Regulation of cathepsin D dependent on the phenotype of colon carcinoma cells

G. Huet, B. Hémon, A. Janin, 1996, International journal of cancer.